SLU researcher develops cancer drug
St. Louis, MO. – A promising cancer-fighting that can bypass a protective blood barrier in the brain was developed by a U.S. Veterans Affairs and Saint Louis University researcher.
The animal study published this week says that feat will enable the compound to fight brain cancer.
The researcher is Dr. William Banks, a pioneer in drug-delivery to the brain.
He showed that the compound, identified by former colleague and Nobel Laureate Andrew Schally of the V.A. and Tulane University, can penetrate the blood brain barrier.
Schally says the next step is to develop it for clinical use. He predicted the drug could be available in up to three years.